Abstract
Background: Accumulating evidence implicates a role for altered energy and proteolytic metabolism in the pathogenesis of Alzheimer disease (AD), but the involvement of erythrocytes (RBC) remains to be completely understood. The objective stands to test a hypotheses that erythrocytic glycolytic and proteolytic metabolism is disturbed in the elderly and in AD patients. Methods: This pilot study analyzed the levels of the key glycolytic and proteolytic enzymes and metabolites in RBC from patients with AD and non-Alzheimer’s dementia (NA), from age-matched (AC) and young adult (YC) controls. Results: Glycolytic enzymes displayed lower activities in AC, and similar or higher activities in AD and NA, as compared to those in YC. Caspase-3 and calpain activities in AC were about 3 times those of YC. There were no differences between AC, AD and NA in proteolytic enzymes. Conclusion: Among glycolytic parameters studied in four subject groups, only hexokinase activity specifically increases in AD. Changes in other glycolytic and proteolytic enzyme activities and metabolite concentrations in RBC were not specific to dementias but characteristics for aging.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Neuroprotection and Neuroregeneration
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
